News

AddToAny

Google+ Facebook Twitter Twitter

Tech news: April

This month's top tech news stories

Menarini Diagnostics
Eye control system for digital dissection

Menarini Diagnostics, one of the UK’s leading suppliers of diagnostic equipment, is expanding its comprehensive cellular pathology portfolio with LOOX eye control system for the MacroPATH digital imaging system range.

It is a completely unique solution that allows the biomedical scientist and pathologist to zoom in and out, take images, videos and audio hands-free, only using their eye movements. This new way of working will therefore minimise contamination at the specimens cut up station. LOOX will additionally increase productivity with providing a more intuitive and engaging hands-free user interaction.

LOOX will replace the mouse, keyboard or foot pedal and can be used with glasses, contact lenses or face shields. LOOX is compatible with the MacroPATH imaging system range (MacroPATH, eGROSS and WorkSTATION) so it can be installed on existing customer systems or for any new installations.

menarinidiag.co.uk

 

Veolia Water Technologies
Purified water

Veolia Water Technologies UK’s PURELAB Quest unit has been selected to provide a complete purified water solution for a newly refurbished laboratory at University College London (UCL). The unit delivers all required types of purified water and was chosen to maximise workspace. Located on the main UCL campus, the Anatomy Building has been undergoing phased updates to much of its interior, including several separate lab areas. 

bit.ly/3qgRVqE

 

 

Related Articles

Diagnose crohn’s with an engineered organism

Researchers have engineered a bacterium with the necessary capabilities for diagnosing a human disease.

Genomic medicine: Coming to the clinic near you?

Dr Rameen Shakur takes a look at how biomedical science and genomics are playing a part in real-world clinical cardiology.

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.

Top